Safety of bisphosphonates in the treatment of osteoporosis
- PMID: 19187809
- DOI: 10.1016/j.amjmed.2008.12.004
Safety of bisphosphonates in the treatment of osteoporosis
Abstract
In this review 4 experts consider the major safety concerns relating to bisphosphonate therapy for osteoporosis. Specific topics covered are skeletal safety (particularly with respect to atypical fractures and delayed healing), gastrointestinal intolerance, hypocalcemia, acute-phase (i.e., postdose) reactions, chronic musculoskeletal pain, renal safety, and cardiovascular safety (specifically, atrial fibrillation).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
